Drug name - Wynzora
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10265265 | MC2 | Topical composition |
Sep, 2027
(4 years from now) | |
Drugs and Companies using BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE ingredient
Treatment: NA
Dosage: CREAM;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.064%;0.005% | CREAM;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.